http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106456603-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3035e0f988a60f96fdb6cad07944cac6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b427e1731ee07c90c322b34e096aec09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b58bf9078ab72b0e0e2dfa8092b960c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aacbf57f16a8fd0220cec5fb15cfb0c2
publicationDate 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106456603-A
titleOfInvention Preparations of mild anticholinergic analogues
abstract Topical formulations comprising libertarian glycopyrronium bromide may be used to treat a hyperhidrosis condition in a subject, such as a human suffering from hyperhidrosis. Preferably, at least one mild anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation capable of inhibiting sweating due to conditions such as hyperhidrosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115175665-A
priorityDate 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7399861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009208437-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467801543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467584402

Total number of triples: 38.